Literature DB >> 30339626

Medical and Surgical Complications and Health-related Quality of Life After Esophageal Cancer Surgery.

Joonas H Kauppila1,2,3, Asif Johar1, Pernilla Lagergren1,4.   

Abstract

OBJECTIVE: To evaluate the impact of postoperative medical and surgical complications on health-related quality of life (HRQOL) in esophageal cancer.
BACKGROUND: Complications after esophageal surgery negatively affect HRQOL, but it is unclear whether medical and surgical complications differ in effects.
METHODS: This Swedish population-based, nationwide, and prospective cohort study enrolled 616 patients undergoing esophageal cancer surgery during 2001 to 2005, with 10 years of follow-up. The exposure was the occurrence of the predefined postoperative medical or surgical technical complications. The study outcome was HRQOL, evaluated by European Organisation for Research and Treatment of Cancer questionnaires at 6 months, and 3, 5, and 10 years after surgery. Linear mixed models, adjusted for confounders and complications, provided mean score differences (MDs) and 95% confidence intervals (CIs) for each HRQOL scale and item.
RESULTS: Of the 616 patients, 217 (35%) had medical and 163 (26%) had surgical postoperative complications. In patients with medical complications, HRQOL was generally worse at all time points, with worse global quality of life (QOL) (MD -10, 95% CI -18 to -2) and dyspnea (MD 16, 95% CI 5-27) from 3 years onwards, compared with those without. Patients with surgical complications had worse HRQOL outcomes up to 5 years after surgery, for example, dyspnea at 6 months (MD 11, 95% CI 4-19) and global QOL at 3 years (MD -13, 95% CI -22 to -5), than those without.
CONCLUSION: Medical complications are associated with long-lasting impairments and worsening HRQOL, whereas the negative effects of surgical complications on HRQOL seem to minimize 5 years postsurgery.

Entities:  

Mesh:

Year:  2020        PMID: 30339626     DOI: 10.1097/SLA.0000000000003097

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  7 in total

1.  Profiling patient-reported symptom recovery from oesophagectomy for patients with oesophageal squamous cell carcinoma: a real-world longitudinal study.

Authors:  Xi Luo; Qin Xie; Qiuling Shi; Yan Miao; Qingsong Yu; Hongfan Yu; Hong Yin; Xuefeng Leng; Yongtao Han; Hong Zhou
Journal:  Support Care Cancer       Date:  2021-11-24       Impact factor: 3.603

2.  Long-Term, Health-Related Quality of Life after Open and Robot-Assisted Ivor-Lewis Procedures-A Propensity Score-Matched Study.

Authors:  Anne-Sophie Mehdorn; Thorben Möller; Frederike Franke; Florian Richter; Jan-Niclas Kersebaum; Thomas Becker; Jan-Hendrik Egberts
Journal:  J Clin Med       Date:  2020-10-30       Impact factor: 4.241

3.  Impact of co-morbidities on health-related quality of life 10 years after surgical treatment of oesophageal cancer.

Authors:  F Klevebro; A Johar; P Lagergren
Journal:  BJS Open       Date:  2020-05-29

4.  Protocol for LAsting Symptoms after Oesophageal Resectional Surgery (LASORS): multicentre validation cohort study.

Authors:  Sheraz Rehan Markar; Ewen A Griffiths; Paul Behrens; Pritam Singh; Ravi S Vohra; James Gossage; Tim Underwood; George B Hanna
Journal:  BMJ Open       Date:  2020-06-03       Impact factor: 2.692

5.  Cancer-Related Fatigue After Esophageal Cancer Surgery: Impact of Postoperative Complications.

Authors:  Zhao Cheng; Asif Johar; Magnus Nilsson; Pernilla Lagergren
Journal:  Ann Surg Oncol       Date:  2021-11-23       Impact factor: 5.344

6.  Body Mass Index-Adjusted Weight Loss Grading System and Cancer-Related Fatigue in Survivors 1 Year After Esophageal Cancer Surgery.

Authors:  Zhao Cheng; Poorna Anandavadivelan; Magnus Nilsson; Asif Johar; Pernilla Lagergren
Journal:  Ann Surg Oncol       Date:  2022-04-01       Impact factor: 4.339

7.  Patient perspectives on key symptoms and preferences for follow-up after upper gastro-intestinal cancer surgery.

Authors:  Philip H Pucher; Annie Coombes; Orla Evans; Joanna Taylor; Jonathan L Moore; Annabelle White; Jesper Lagergren; Cara Baker; Mark Kelly; James A Gossage; Jason Dunn; Sebastian Zeki; Ben E Byrne; Jervoise Andreyev; Andrew R Davies
Journal:  Support Care Cancer       Date:  2022-03-11       Impact factor: 3.359

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.